Showing results (601-610 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|December 24, 2002
Distress due to unwanted side-effects of prostate cancer treatment is related to impaired well-being (quality of life)AR Helgason, J Adolfsson, P Dickman, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Increased glyceraldehyde-3-phosphate dehydrogenase gene expression in late pathological stage human prostate cancerR H Rondinelli, D E Epner, J V Tricoli
Prostate Cancer and Prostatic Diseases|December 24, 2002
Prevalence of prostatic intra-epithelial neoplasia (PIN) in biopsies from hospital practice and pilot screening: clinical implicationsM R Feneley, J S A Green, M P A Young, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Doxazosin in the treatment of benign prostatic hyperplasia. A review of the safety profile in older patientsR Kirby, A Jardin
Prostate Cancer and Prostatic Diseases|December 24, 2002
Aneuploidy and rapid cell proliferation in recurrent prostate cancers with androgen receptor gene amplificationP Koivisto
Prostate Cancer and Prostatic Diseases|December 24, 2002
Combined analysis of two multicenter studies of finasteride 5 mg in the treatment of symptomatic benign prostatic hyperplasiaC A Byrnes, C L Liss, J L Tenover, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
Prognostic significance of angiogenesis in clinically localized prostate cancer (staining for Factor VIII-related antigen and CD34 AntigenA Arakawa, S Soh, S Chakraborty, et al.
Prostate Cancer and Prostatic Diseases|December 24, 2002
The relation of p53 protein nuclear accumulation and angiogenesis in human prostatic carcinomaE Y Yu, E Yu, G E Meyer, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2003
Dependence of metastatic cancer cell invasion on MLCK-catalyzed phosphorylation of myosin regulatory light chainR Tohtong, K Phattarasakul, A Jiraviriyakul, et al.
Prostate Cancer and Prostatic Diseases|September 13, 2003
Expression of matrix metalloproteinases (MMP-2 and -9) and their inhibitors (TIMP-1 and -2) in prostate cancer tissueB Brehmer, S Biesterfeld, G Jakse
Pageof 199